← Back to Search

Autism Access Link for Early Referral and Treatment (Autism ALERT Trial)

N/A
Waitlist Available
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
child's primary care provider suspects the child has ASD, child is patient at one of the study clinics, child age 12 to 54 months, family speaks English or Spanish, no prior ASD medical diagnosis or ASD diagnostic evaluation
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after enrollment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new way to help kids with suspected ASD receive the resources they need by making it easier for primary care providers to refer them and track their progress.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at enrollment and 6 months after enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and at enrollment and 6 months after enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
% referred to program who complete an ASD educational evaluation within 6 months
Change in Family Centered and Coordinated Care
Change in Family Empowerment
+7 more
Secondary study objectives
% with ASD determination receiving ASD services 6 months after enrollment
% with ASD medical diagnosis receiving ASD therapy 6 months after enrollment, among children on Medicaid
Age of EI/ECSE educational determination, among children with ASD
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Screening + Autism ALERTExperimental Treatment2 Interventions
Clinics in the intervention arm receive Autism ALERT plus an ASD screening intervention (START Autism).
Group II: Screening OnlyActive Control1 Intervention
Clinics in the comparison intervention (control) arm receive the ASD screening intervention only (START Autism).

Find a Location

Who is running the clinical trial?

Providence Health & ServicesOTHER
124 Previous Clinical Trials
823,615 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
500 Patients Enrolled for Autism Spectrum Disorder
Boston Medical CenterOTHER
404 Previous Clinical Trials
884,757 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
383 Patients Enrolled for Autism Spectrum Disorder
Oregon Health and Science UniversityLead Sponsor
1,006 Previous Clinical Trials
7,413,964 Total Patients Enrolled
6 Trials studying Autism Spectrum Disorder
1,183 Patients Enrolled for Autism Spectrum Disorder
~31 spots leftby Dec 2025